Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Oncology Reports
|
October 27, 2015
Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-κB signaling pathway
Qi Li, Yiming Lai, Chengbin Wang, et al.
Cancer Pathogenesis and Therapy
|
October 7, 2024
Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study
Peixian Chen, Yue Wang, Zhi Xiong, et al.
Oncology Letters
|
November 9, 2018
High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer
Xiaoming Ma, Tao Du, Dingjun Zhu, et al.
Frontiers in Oncology
|
October 14, 2022
Bibliometric analysis of the global research development of bone metastases in prostate cancer: A 22-year study
Yongming Chen, Chen Tang, Zefeng Shen, et al.
Environmental Toxicology
|
November 16, 2023
MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer
Bisheng Cheng, Yiming Lai, Hao Huang, et al.
Cancer
|
June 14, 2014
Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer
Yiming Zhang, Hai Huang, Huimin Zhou, et al.
Urologic Oncology
|
May 16, 2020
PD-1 topographically defines distinct T cell subpopulations in urothelial cell carcinoma of the bladder and predicts patient survival
Weibin Hou, Miaoxin Xue, Juanyi Shi, et al.
International Journal of Oncology
|
December 22, 2016
Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway
Hai Huang, Tao Du, Guibin Xu, et al.
Cell & Bioscience
|
February 2, 2024
Correction: The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment
Bisheng Cheng, Lingfeng Li, Yongxin Wu, et al.
Oncology Letters
|
April 5, 2019
Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer
Wanhua Wu, Shoumin Bai, Dingjun Zhu, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Oncology Reports
|
October 27, 2015
Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-κB signaling pathway
Qi Li, Yiming Lai, Chengbin Wang, et al.
Cancer Pathogenesis and Therapy
|
October 7, 2024
Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study
Peixian Chen, Yue Wang, Zhi Xiong, et al.
Oncology Letters
|
November 9, 2018
High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer
Xiaoming Ma, Tao Du, Dingjun Zhu, et al.
Frontiers in Oncology
|
October 14, 2022
Bibliometric analysis of the global research development of bone metastases in prostate cancer: A 22-year study
Yongming Chen, Chen Tang, Zefeng Shen, et al.
Environmental Toxicology
|
November 16, 2023
MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer
Bisheng Cheng, Yiming Lai, Hao Huang, et al.
Cancer
|
June 14, 2014
Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer
Yiming Zhang, Hai Huang, Huimin Zhou, et al.
Urologic Oncology
|
May 16, 2020
PD-1 topographically defines distinct T cell subpopulations in urothelial cell carcinoma of the bladder and predicts patient survival
Weibin Hou, Miaoxin Xue, Juanyi Shi, et al.
International Journal of Oncology
|
December 22, 2016
Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway
Hai Huang, Tao Du, Guibin Xu, et al.
Cell & Bioscience
|
February 2, 2024
Correction: The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment
Bisheng Cheng, Lingfeng Li, Yongxin Wu, et al.
Oncology Letters
|
April 5, 2019
Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer
Wanhua Wu, Shoumin Bai, Dingjun Zhu, et al.
Page
of 6